RA Capital Healthcare Fund LP bought $25.3M of Janux Therapeutics (JANX)

Executed Mar 5 2025, disclosed Mar 7 2025, 2 days later.

Value, as filed

$25.3M

824,041 sh across 4 lots

Executed

Mar 5 2025

the trade date, as filed

Disclosed

Mar 7 2025

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

-15.9%

-6.8% from execution

Over the 21 trading sessions from the disclosed entry session (Mar 7 2025), the stock returned -15.9% (delay-adjusted); from the execution session (Mar 5 2025), -6.8%. Derived: entry at the session's open, exit at the close 20 sessions later.

The filer

RL RA Capital Healthcare Fund LP Director profile →

RA Capital Healthcare Fund LP (Director) filed 1 Form 4 report as a reporting entity in the trailing twelve months (0 purchases, 1 sale), most often in TYRA. The largest single filing was $58.4M of FULC (4,175,139 sh across 3 lots, as filed), executed Dec 8 2025.

The name

JANX JANX JANX · 18 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→